1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Cyclophosphamate: new trials by email Literature Review of Cyclophosphamate trials Research Report on Cyclophosphamate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Iopofosine I 131 vs. R-CD in WM Patients Iopofosine I 131, Rituximab (active comparator), Cyclophosphamate - Waldenstrom Macroglobulinaemia, Waldenstrom Macroglobulinemia | Phase 3 | Not yet recruiting | Cellectar Biosciences, Inc. | 219 | 2026-12-01 | 2026-08-14 |
| Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma Lymphodepleting chemotherapy, Dexamethasone, Fludarabine - Clear Cell Carcinoma, Phase 1 | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 30 | 2025-09-25 | 2026-04-29 |
| Effects of an Anti-Inflammatory Drug in Alzheimer's Disease Cyclophosphamate - Alzheimer's Disease | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 60 | 2001-03-22 | 2017-07-02 |
Adenocarcinoma, Clear Cell (1) · Alzheimer Disease (1) · Waldenstrom Macroglobulinemia (1)
Cellectar Biosciences, Inc. (1) · M.D. Anderson Cancer Center (1) · National Institute of Mental Health (NIMH) (1)
United States (2)